Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Amphotericin B Schedules vs Voriconazole for Fungal Prophylaxis in AML/MDS
NCT00418951Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2006
- Primary completion
- Oct 2009
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal amphotericin b in invasive fungal infection (IFI), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2006; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00418951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418951.